SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming
Abstract Background Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality globally, significantly impacting worldwide health. Hence, identifying key molecular drivers of HCC progression is crucial for enhancing treatment options and prognostic methods. This study explores the f...
Saved in:
| Main Authors: | Xin Jin, Xigan He, Runze Huang, Qinyu Liu, Lei Wang, Xuanci Bai, Yibin Wu, Yixiu Wang, Ziting Jiang, Yi Shi, Gautam Sethi, Lu Wang, Weiping Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03463-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SNRPB2 facilitates esophageal squamous cell carcinoma oncogenesis and progression via E2F4 stabilization
by: Feng Xu, et al.
Published: (2025-06-01) -
SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via β-catenin/c-Myc signaling
by: Jiaqian Bao, et al.
Published: (2025-04-01) -
Genetic evidence for causal links between diet, gut microbiota, and hepatobiliary cancer: a Mendelian randomization study
by: Runze Huang, et al.
Published: (2025-07-01) -
Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study
by: Zhilan Zhang, et al.
Published: (2025-03-01) -
CHML regulates migration and invasion in hepatocellular carcinoma via transcriptional and metabolic reprogramming
by: Huanqian Cao, et al.
Published: (2025-08-01)